Literature DB >> 4202683

Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin.

J Klastersky, A Henri, C Hensgens, D Daneau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4202683     DOI： 10.1001/jama.227.1.45

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  17 in total

Review 1.  Principles of combination therapy.

Authors:  S Levin; A A Harris
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Synergism and antagonism among antimicrobial drugs. A personal perspective.

Authors:  E Jawetz
Journal:  West J Med       Date:  1975-08

3.  Editorials: Combination antimicrobial therapy.

Authors:  R G Petersdorf
Journal:  West J Med       Date:  1975-08

Review 4.  Infectious diseases: fortieth and final annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1975-09       Impact factor: 2.401

5.  Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.

Authors:  J Kuhlmann; G Seidel; H Grötsch
Journal:  Infection       Date:  1982       Impact factor: 3.553

6.  Imipenem-cilastatin as initial therapy for febrile cancer patients.

Authors:  G P Bodey; M E Alvarez; P G Jones; K V Rolston; L Steelhammer; V Fainstein
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

7.  Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.

Authors:  R E Scott; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

8.  Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.

Authors:  S C Schimpff; S Landesman; D M Hahn; H C Standiford; C L Fortner; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

9.  Carbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind study.

Authors:  J Klastersky; L Coppens; F Meunier-Carpentier; A P Menday
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

10.  Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children.

Authors:  R F Jacobs; T S Vats; K A Pappa; S Chaudhary; M Kletzel; D L Becton
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.